The 6 linked references in paper M. Pak B., A. Mudunov M., L. Demidov V., R. Azizyan I., V. Brzhezovskiy Zh., D. Stelmakh K., Ya. Bozhchenko A., A. Ignatova V., М. Пак Б., А. Мудунов М., Л. Демидов В., Р. Азизян И., В. Бржезовский Ж., Д. Стельмах К., Я. Божченко А., А. Игнатова В. (2017) “Влияние морфологических факторов прогноза на отдаленные результаты лечения больных с меланомой кожи головы и шеи // Effect of morphological prognostic factors on long-term treatment results in patients with head and neck skin melanoma” / spz:neicon:ogsh:y:2017:i:1:p:61-68

  1. Balch C.M., Buzaid A.C., Soong S.-J. et al. Final version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol 2001;19:3635–48. DOI: 10.1200/JCO.2001.19.16.3635. PMID: 11504745
  2. Balch C.M., Buzaid A.C., Soong S.-J. et al. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol 2003;21:43–52. DOI: 10.1002/ssu.10020. PMID: 12923915
  3. Azzola M.F., Shaw H.M., Thompson J.F. et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma. Cancer 2003;97:1488–98. DOI: 10.1002/cncr.11196. PMID: 12627514
  4. Francken A.B., Shaw H.M., Thompson J.F. et al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 2004;11:426–33. DOI: 10.1245/ASO.2004.07.014. PMID: 15070604
  5. Kesmodel S.B., Karakousis G.C., Botbyl J.D. et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 2005;12(6):449–58. DOI: 10.1245/ASO.2005.04.027. PMID: 15864482
  6. Balch C.M., Gershenwald J.E., Soong S.J. et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27(36):6199–206. DOI: 10.1200/JCO.2009.23.4799.